AspenBio Pharma, Inc.·4

Jan 9, 10:37 AM ET

Donnelly Richard G 4

4 · AspenBio Pharma, Inc. · Filed Jan 9, 2006

Insider Transaction Report

Form 4
Period: 2005-12-28
Donnelly Richard G
DirectorPresident & CEO
Transactions
  • Award

    Common Stock

    2005-12-28$0.95/sh+5,000$4,75080,823 total
Holdings
  • Options (Right to Buy)

    Exercise: $0.60From: 2005-02-01Exp: 2015-02-01Common Stock (500,000 underlying)
    500,000
  • Warrants (Right to Buy)

    Exercise: $1.35From: 2005-05-06Exp: 2010-05-06Common Stock (28,571 underlying)
    28,571
Footnotes (2)
  • [F1]Options best over three years, at the rate of 33.3% at the end of year one, 66.7% at the end of year two, and 100% at the end of year three.
  • [F2]Units purchased at a unit price of $0.875, with each unit consisting of one warrant and one share of common stock.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT